Long COVID Treatment with Low Dose Naltrexone (LDN)

According to the CDC, long COVID affects 1 in 13 adults in the U.S. (7.5%), with symptoms lasting over three months. As of July 2022, over 40% of U.S. adults had COVID-19, and 19% reported long COVID symptoms. Though naltrexone is typically used to treat addiction to opioids or alcohol, preliminary research suggests that low-dose […]